[1]
N. Mohan, D. Yoganandan, K. Mohanasundaram, K. V. Rajalakshmi, and S. M. Kumar, “Rapidly progressing treatment resistant anti-TIF1 gamma antibody positive dermatomyositis”, Int J Adv Med, vol. 9, no. 3, pp. 342–345, Feb. 2022.